J&J hit with $21.7 million verdict in another talc asbestos cancer case

NEW YORK (Reuters) - Johnson & Johnson and its talc suppliers on Wednesday were hit with a $21.7 million jury verdict in a lawsuit by a woman who said she developed cancer after being exposed to asbestos in the company's Baby Powder.

Novartis receives EU approval for biosimilar Zessly

ZURICH (Reuters) - Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in gastroenterological, rheumatological and dermatological diseases.

U.S. to send experimental Ebola treatment to Congo - official

CHICAGO (Reuters) - U.S. health authorities said on Wednesday they were preparing to send an experimental Ebola treatment to the Democratic Republic of Congo for use in a clinical trial aimed at stemming an outbreak in the country that has spread to Mbandaka, a city of about 1.5 million people.

Why the world needs more than one Ebola vaccine

LONDON (Reuters) - - In the life-and-death race to make the first effective vaccine against Ebola, one company - Merck - seems bound to win.

Second Indian state reports suspected cases of rare virus, fanning fears of spread

KOCHI/MUMBAI (Reuters) - Indian health officials were checking on Wednesday if a rare, brain-damaging virus had spread to a second state after two suspected cases reported in southern Karnataka, as the death toll in adjacent Kerala, where the outbreak began, rose to 11.

Merck's cancer drug Keytruda notches another trial success

(Reuters) - Merck & Co said on Wednesday its drug Keytruda helped patients with a certain type of lung cancer live longer and prevented the disease from spreading, helping to solidify its position in the lucrative cancer market.

Ebola patients slip out of Congo hospital as medics try to curb outbreak

MBANDAKA, Democratic Republic of Congo (Reuters) - Three patients infected with the Ebola virus slipped out of an isolation ward at a hospital in Democratic Republic of Congo, health officials said, as medics raced to stop the deadly disease from spreading in the busy river port of Mbandaka.

Money a better motivator to stop smoking than free e-cigs or quit aids

(Reuters Health) - Providing free electronic cigarettes or other stop-smoking products to employees to get them to give up real cigarettes is less effective than the threat of taking away a cash reward for quitting, according to a new study that weighs the effectiveness of a variety of workplace incentive programs.

Smartphone app not good enough to track blood pressure in pregnancy

(Reuters Health) - A smartphone app may not be an effective method of measuring blood pressure in pregnant women, a small experiment suggests.

Blood test may predict who is most at risk for diabetes

(Reuters Health) - Adding a test normally used for diabetes monitoring to employee wellness exams could identify people who don't have the disease but are at high risk of developing it, a recent study suggests.

Related Videos

Aquatic moss that removes arsenic from water discovered

Hybrid-electric aircraft race heats up

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here